» Articles » PMID: 36698933

Triglyceride-glucose Index and Estimated 10-year Risk of a First Hard Cardiovascular Event

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whether Triglyceride-glucose (TyG) index is associated with 10-year risk of a first hard atherosclerotic cardiovascular disease (ASCVD) event in the United States remains unclear.

Methods: In this cross-sectional study, the participants, ranged from 40 to 79 years old, were from the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2018. TyG index was the independent variable and 10-year risk of a first hard ASCVD was the dependent variable. The other variables, such as age, gender, race, body mass index (BMI), hypertension treatment states, smoking states and low-density lipoprotein cholesterol (LDL-C) et al. were considered as the potential confounding factors. Multivariate linear regression models and smooth curve fittings were used to evaluate the association between TyG index and 10-year risk of a first hard ASCVD event.

Results: A total of 2,142 participants were included in the analysis. The results showed that TyG index was associated with an increased 10-year risk of a first hard ASCVD event [β = 2.208, 95% (1.716, 2.700), < 0.00001]. The association had statistical significance in both men [β = 3.862 95% CI (3.274, 4.450), < 0.00001] and women [β = 1.067, 95% CI (0.286, 1.849), = 0.00756)] according to subgroup analysis. Smooth curve fittings revealed that TyG index was linearly associated with 10-year risk of ASCVD in both male and female.

Conclusion: Triglyceride-glucose index was associated with an increased 10-year risk of a first hard ASCVD event in the United States, suggesting it is necessary to monitor and control an appropriate range of TyG index.

Citing Articles

In vitro characterization of radiofrequency ablation lesions in equine and swine myocardial tissue.

Buschmann E, Van Steenkiste G, Duytschaever M, Segers P, Ibrahim L, van Loon G Sci Rep. 2024; 14(1):22877.

PMID: 39358479 PMC: 11447003. DOI: 10.1038/s41598-024-74486-2.


Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.

Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y Cardiovasc Diabetol. 2024; 23(1):262.

PMID: 39026233 PMC: 11264797. DOI: 10.1186/s12933-024-02354-4.


Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort.

Xia X, Chen S, Tian X, Xu Q, Zhang Y, Zhang X Cardiovasc Diabetol. 2024; 23(1):208.

PMID: 38898520 PMC: 11188278. DOI: 10.1186/s12933-024-02290-3.


Association between the triglyceride glucose index and atherosclerotic cardiovascular disease in the general population: analysis of the national health and nutrition examination survey 1999-2004.

Jihong S, Xiaojie C, He L, Yifan Z Front Endocrinol (Lausanne). 2024; 15:1376357.

PMID: 38836226 PMC: 11148275. DOI: 10.3389/fendo.2024.1376357.


Association of the triglyceride-glucose index with early-onset atherosclerotic cardiovascular disease events and all-cause mortality: a prospective cohort study.

Hou Q, Qi Q, Han Q, Yu J, Wu J, Yang H Cardiovasc Diabetol. 2024; 23(1):149.

PMID: 38685099 PMC: 11059708. DOI: 10.1186/s12933-024-02249-4.


References
1.
Barquera S, Pedroza-Tobias A, Medina C, Hernandez-Barrera L, Bibbins-Domingo K, Lozano R . Global Overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res. 2015; 46(5):328-38. DOI: 10.1016/j.arcmed.2015.06.006. View

2.
Mahtta D, Khalid U, Misra A, Samad Z, Nasir K, Virani S . Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently?. Curr Atheroscler Rep. 2020; 22(9):44. DOI: 10.1007/s11883-020-00862-8. View

3.
Gao J, Hao Q, Gao M, Zhang K, Li X, Wang J . Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovasc Diabetol. 2021; 20(1):126. PMC: 8223290. DOI: 10.1186/s12933-021-01319-1. View

4.
Ding X, Wang X, Wu J, Zhang M, Cui M . Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021; 20(1):76. PMC: 8019501. DOI: 10.1186/s12933-021-01268-9. View

5.
Patrono C, Morais J, Baigent C, Collet J, Fitzgerald D, Halvorsen S . Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. J Am Coll Cardiol. 2017; 70(14):1760-1776. DOI: 10.1016/j.jacc.2017.08.037. View